ADC Therapeutics SA - Common Shares, par value CHF 0.08 per share (ADCT)
CUSIP: H0036K147
Q4 2023 13F Holders as of 31 Dec 2023
- Type / Class
- Equity / Common Shares, par value CHF 0.08 per share
- Shares outstanding
- 128,459,465
- Total 13F shares
- 33,953,461
- Share change
- -5,557,588
- Total reported value
- $56,361,695
- Price per share
- $1.66
- Number of holders
- 36
- Value change
- -$3,915,509
- Number of buys
- 12
- Number of sells
- 19
Quarterly Holders Quick Answers
What is CUSIP H0036K147?
CUSIP H0036K147 identifies ADCT - ADC Therapeutics SA - Common Shares, par value CHF 0.08 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP H0036K147:
Top shareholders of ADCT - ADC Therapeutics SA - Common Shares, par value CHF 0.08 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Redmile Group, LLC |
13F
|
Company |
11%
|
14,178,045
|
$12,717,706 | — | 30 Sep 2023 | |
| Prosight Management, LP |
13F
|
Company |
4.2%
|
5,402,041
|
$4,845,631 | — | 30 Sep 2023 | |
| Sio Capital Management, LLC |
13F
|
Company |
2.6%
|
3,294,534
|
$2,955,197 | — | 30 Sep 2023 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
2.3%
|
2,898,121
|
$2,599,614 | — | 30 Sep 2023 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
2.1%
|
2,650,251
|
$2,377,275 | — | 30 Sep 2023 | |
| Frazier Life Sciences Management, L.P. |
13F
|
Company |
1.3%
|
1,647,030
|
$1,477,386 | — | 30 Sep 2023 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
1.2%
|
1,533,931
|
$1,375,936 | — | 30 Sep 2023 | |
| Affinity Asset Advisors, LLC |
13F
|
Company |
0.86%
|
1,100,000
|
$986,700 | — | 30 Sep 2023 | |
| AlphaCentric Advisors LLC |
13F
|
Company |
0.83%
|
1,068,468
|
$958,416 | — | 30 Sep 2023 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.82%
|
1,052,978
|
$944,521 | — | 30 Sep 2023 | |
| Vantage Consulting Group Inc |
13F
|
Company |
0.66%
|
850,737
|
$763,111 | — | 30 Sep 2023 | |
| Blue Owl Capital Holdings LP |
13F
|
Company |
0.57%
|
733,568
|
$654,489 | — | 30 Sep 2023 | |
| MORGAN STANLEY |
13F
|
Company |
0.52%
|
664,027
|
$595,632 | — | 30 Sep 2023 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0.41%
|
529,890
|
$475,311 | — | 30 Sep 2023 | |
| MARSHALL WACE, LLP |
13F
|
Company |
0.34%
|
438,673
|
$394,806 | — | 30 Sep 2023 | |
| GCM Grosvenor Holdings, LLC |
13F
|
Company |
0.32%
|
410,888
|
$368,567 | — | 30 Sep 2023 | |
| Nantahala Capital Management, LLC |
13F
|
Company |
0.2%
|
257,162
|
$230,674 | — | 30 Sep 2023 | |
| ACADIAN ASSET MANAGEMENT LLC |
13F
|
Company |
0.12%
|
156,048
|
$138,000 | — | 30 Sep 2023 | |
| GSA CAPITAL PARTNERS LLP |
13F
|
Company |
0.09%
|
121,897
|
$109,000 | — | 30 Sep 2023 | |
| Indie Asset Partners, LLC |
13F
|
Company |
0.07%
|
92,700
|
$83,152 | — | 30 Sep 2023 | |
| Composition Wealth, LLC |
13F
|
Company |
0.07%
|
84,496
|
$75,793 | — | 30 Sep 2023 | |
| XTX Topco Ltd |
13F
|
Company |
0.05%
|
67,051
|
$60,145 | — | 30 Sep 2023 | |
| Hennion & Walsh Asset Management, Inc. |
13F
|
Company |
0.05%
|
57,867
|
$51,907 | — | 30 Sep 2023 | |
| Magnetar Financial LLC |
13F
|
Company |
0.04%
|
55,762
|
$50,019 | — | 30 Sep 2023 | |
| OSAIC HOLDINGS, INC. |
13F
|
Company |
0.02%
|
22,629
|
$20,297 | — | 30 Sep 2023 | |
| ELCO Management Co., LLC |
13F
|
Company |
0.02%
|
21,532
|
$19,314 | — | 30 Sep 2023 | |
| Gladius Capital Management LP |
13F
|
Company |
0.02%
|
19,752
|
$17,718 | — | 30 Sep 2023 | |
| MONETA GROUP INVESTMENT ADVISORS LLC |
13F
|
Company |
0.02%
|
19,496
|
$17,488 | — | 30 Sep 2023 | |
| EVERGREEN CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.01%
|
11,000
|
$9,867 | — | 30 Sep 2023 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0.01%
|
7,939
|
$8,000 | — | 30 Sep 2023 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0%
|
4,120
|
$3,696 | — | 30 Sep 2023 | |
| GROUP ONE TRADING LLC |
13F
|
Company |
0%
|
2,232
|
$2,002 | — | 30 Sep 2023 | |
| FMR LLC |
13F
|
Company |
0%
|
1,315
|
$1,179 | — | 30 Sep 2023 | |
| Cutler Group LLC / CA |
13F
|
Company |
0%
|
1,400
|
$1,000 | — | 30 Sep 2023 | |
| SIMPLEX TRADING, LLC |
13F
|
Company |
0%
|
1,232
|
$1,000 | — | 30 Sep 2023 | |
| Focused Wealth Management, Inc |
13F
|
Company |
0%
|
300
|
$269 | — | 30 Sep 2023 | |
| US BANCORP \DE\ |
13F
|
Company |
0%
|
300
|
$269 | — | 30 Sep 2023 | |
| PNC FINANCIAL SERVICES GROUP, INC. |
13F
|
Company |
0%
|
250
|
$224 | — | 30 Sep 2023 | |
| Qube Research & Technologies Ltd |
13F
|
Company |
0%
|
207
|
$186 | — | 30 Sep 2023 | |
| Federation Des Caisses Desjardins du Quebec |
13F
|
Individual |
0%
|
20
|
$18 | — | 30 Sep 2023 | |
| Cornerstone Planning Group LLC |
13F
|
Company |
0%
|
14
|
$13 | — | 30 Sep 2023 | |
| HUNTINGTON NATIONAL BANK |
13F
|
Company |
—
class O/S missing
|
1
|
$13 | — | 30 Sep 2023 |
Institutional Holders of ADC Therapeutics SA - Common Shares, par value CHF 0.08 per share (ADCT) as of Q4 2023
As of 31 Dec 2023,
ADC Therapeutics SA - Common Shares, par value CHF 0.08 per share (ADCT) was held by
36 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
33,953,461 shares.
The largest 10 holders included
Redmile Group, LLC, Prosight Management, LP, MILLENNIUM MANAGEMENT LLC, CITADEL ADVISORS LLC, BANK OF AMERICA CORP /DE/, GOLDMAN SACHS GROUP INC, Affinity Asset Advisors, LLC, Vantage Consulting Group Inc, MORGAN STANLEY, and Blue Owl Capital Holdings LP.
This page lists
36
institutional shareholders reporting positions in this security
for the Q4 2023 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2023 vs Q3 2023 Across Filers
Q3 2023 holders
40
Q4 2023 holders
36
Holder diff
-4
| Investor | Q3 2023 Shares | Q4 2023 Shares | Share Diff | Share Chg % | Q3 2023 Value $ | Q4 2023 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.